Chloroquine inhibits glutamate-induced death of a neuronal cell line by reducing reactive oxygen species through sigma-1 receptor.
Yoko Hirata, Hideko Yamamoto, Mostafa Shukry Moursy Atta, Shawky Mahmoud, Kentaro Oh-hashi, Kazutoshi Kiuchi
Index: J. Neurochem. 119(4) , 839-47, (2011)
Full Text: HTML
Abstract
Chloroquine, a widely used anti-malarial and anti-rheumatoid agent, has been reported to induce apoptotic and non-apoptotic cell death. Accumulating evidence now suggests that chloroquine can sensitize cancer cells to cell death and augment chemotherapy-induced apoptosis by inhibiting autophagy. However, chloroquine is reported to induce GM1 ganglioside accumulation in cultured cells at low μM concentrations and prevent damage to the blood brain barrier in mice. It remains unknown whether chloroquine has neuroprotective properties at concentrations below its reported ability to inhibit lysosomal enzymes and autophagy. In the present study, we demonstrated that chloroquine protected mouse hippocampal HT22 cells from glutamate-induced oxidative stress by attenuating production of excess reactive oxygen species. The concentration of chloroquine required to rescue HT22 cells from oxidative stress was much lower than that sufficient enough to induce cell death and inhibit autophagy. Chloroquine increased GM1 level in HT22 cells at low μM concentrations but glutamate-induced cell death occurred before GM1 accumulation, suggesting that GM1 induction is not related to the protective effect of chloroquine against glutamate-induced cell death. Interestingly, BD1047 and NE-100, sigma-1 receptor antagonists, abrogated the protective effect of chloroquine against glutamate-induced cell death and reactive oxygen species production. In addition, cutamesine (SA4503), a sigma-1 receptor agonist, prevented both glutamate-induced cell death and reactive oxygen species production. These findings indicate that chloroquine at concentrations below its ability to inhibit autophagy and induce cell death is able to rescue HT22 cells from glutamate-induced cell death by reducing excessive production of reactive oxygen species through sigma-1 receptors. These results suggest potential use of chloroquine, an established anti-malarial agent, as a neuroprotectant against oxidative stress, which occurs in a variety of neurodegenerative diseases.© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.
Related Compounds
Related Articles:
2013-10-15
[Am. J. Physiol. Heart Circ. Physiol. 305(8) , H1201-12, (2013)]
2013-05-17
[Biochem. Biophys. Res. Commun. 434(4) , 904-9, (2013)]
2006-02-01
[Curr. Drug Metab. 7(2) , 135-46, (2006)]
2006-04-24
[Eur. J. Pharmacol. 536(1-2) , 200-3, (2006)]
Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity.
2005-08-01
[Neuroreport 16(11) , 1223-6, (2005)]